The global neurovascular stent market was valued at $555 million in 2022 and is expected to grow at a CAGR of 6.1% during the forecast period, reaching $840 million. The full report suite on the global neurovascular stent market includes traditional neurovascular stents, flow diversion stents, and intrasaccular stents, reflecting the diversity of products available in the market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL NEUROVASCULAR STENT MARKET INSIGHTS
One of the primary drivers of the neurovascular stent market is the continuous enhancement of stent technology. These advancements make stent procedures quicker and safer, lowering patient risk and minimizing physician resistance to stenting products. However, some older-generation neurosurgeons who are not accustomed to using neurovascular stents may exhibit bias towards this relatively new technology in the interventional neuroradiology market.GLOBAL NEUROVASCULAR STENT MARKET SHARE INSIGHTS
Within the global market for neurovascular stent, there are three key market players - Medtronic, MicroVention, Stryker. In 2022, Medtronic was the leader in the global neurovascular stent market. It currently offers the Pipeline™Flex and the first-generation of the flow diverting stent.MARKET SEGMENTATION SUMMARY
- Global Traditional Stent Market
- Global Flow Diversion Stent Market
- Global Intrasaccular Stent Market
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast: 2023-2029
- Historical Data: 2019-2022
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.
Table of Contents
- Neurovascular Stent Market
- Executive Summary
- Global Neurovascular Stent Market Overview
- Competitive Analysis
- Markets Included
- Regions Included
- Introduction
- Procedure Numbers
- Total Neurovascular Stent Procedures
- Market Overview
- By Segment
- By Region
- Market Analysis and Forecast
- Total Neurovascular Stent Market
- Traditional Neurovascular Stent Market
- Flow Diversion Stent Market
- Intrasaccular Stent Market
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- MicroVention
- Stryker
- Phenox
- Balt
- Cerenovus
- Cerus Endovascular
- Acandis
- MicroPort
